Robert Paul Discordia, Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 2,500 shares at $4.62 ($12K) on 2019-11-11, disclosed to the SEC on 2019-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |